Topcon Corporation
14
0
0
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
21.4%
3 terminated/withdrawn out of 14 trials
78.6%
-7.9% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Screening Protocol
Role: lead
Agreement and Precision Study
Role: lead
An Age-Stratified Data Collection Study to Establish a Normative Database Using the 3D Optical Coherence Tomography 3D OCT-1000 Mark II
Role: lead
Lamina Cribrosa Depth Change With Change in Eye Pressure
Role: collaborator
TRK-3 Conformance to Standards for Tonometers
Role: lead
TRK-3 Performance of Pachymetry
Role: lead
OCT Angiography Software Evaluation Study
Role: lead
Topcon DRI OCT Triton With SS-OCT Angio Software Evaluation Study
Role: lead
Clinical Study of the Topcon Pachymeter TRK-3 to Evaluate Agreement and Precision
Role: lead
Clinical Study of the Topcon Tonometer TRK-3
Role: lead
Triton Reference Database
Role: lead
NW500 Non-Mydriatic Retinal Camera Clinical Performance Study
Role: lead
Sub-threshold Photocoagulation of Diabetic Macular Oedema
Role: collaborator
Topcon Endpoint Management
Role: collaborator
All 14 trials loaded